novo nordisk cagrilintide Nordisk's stock drops despite CagriSema hitting goal of Phase III trial NVO Stock Rises on Upbeat

The vitamin B12 injection supplies additional B12 to those who need it

Risks and Safety Considerations You Should Be Aware Of Using unlicensed retatrutide carries serious risks including unknown purity, infection from non-sterile technique, unmonitored adverse effects such as nausea and increased heart rate, and potential drug interactions

Arab J Urol

For patients with severe vitamin B12 deficiency or pernicious anemia, our initial treatment protocol may involve more frequent injections, such as daily or every other day for one to two weeks

No clinical trial has tested this combination, and it is not recommended

Research into predictive biomarkers could improve patient selection and treatment monitoring